Kiichiro Ueta

2.3k total citations
38 papers, 1.9k citations indexed

About

Kiichiro Ueta is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Kiichiro Ueta has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 22 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Molecular Biology. Recurrent topics in Kiichiro Ueta's work include Diabetes Treatment and Management (22 papers), Pancreatic function and diabetes (22 papers) and Metabolism, Diabetes, and Cancer (16 papers). Kiichiro Ueta is often cited by papers focused on Diabetes Treatment and Management (22 papers), Pancreatic function and diabetes (22 papers) and Metabolism, Diabetes, and Cancer (16 papers). Kiichiro Ueta collaborates with scholars based in Japan, United States and Norway. Kiichiro Ueta's co-authors include Akira Oku, Akira Saito, Kenji Arakawa, Masao Nawano, Mamoru Matsumoto, Keiko Nakayama, Tomomi Ishihara, Minoru Tsuda-Tsukimoto, Mitsuya Hongu and Chiaki Kuriyama and has published in prestigious journals such as PLoS ONE, Diabetes and Biochemical and Biophysical Research Communications.

In The Last Decade

Kiichiro Ueta

37 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiichiro Ueta Japan 23 1.2k 855 813 271 174 38 1.9k
Terrance D. Barrett United States 17 772 0.6× 403 0.5× 557 0.7× 97 0.4× 98 0.6× 43 1.6k
Uday Saxena United States 26 698 0.6× 542 0.6× 649 0.8× 96 0.4× 214 1.2× 54 2.1k
Shlomo Keidar Israel 27 957 0.8× 1.0k 1.2× 503 0.6× 62 0.2× 194 1.1× 61 2.9k
Amit Joharapurkar India 23 416 0.3× 242 0.3× 489 0.6× 126 0.5× 163 0.9× 71 1.3k
Mark C. Kowala United States 24 273 0.2× 618 0.7× 640 0.8× 118 0.4× 362 2.1× 56 1.9k
J L Witztum United States 15 564 0.5× 830 1.0× 704 0.9× 156 0.6× 215 1.2× 23 3.3k
Gert M. Kostner Austria 31 539 0.4× 986 1.2× 501 0.6× 53 0.2× 413 2.4× 61 2.5k
Timothy J. Furlong Australia 14 593 0.5× 349 0.4× 1.0k 1.3× 50 0.2× 154 0.9× 31 1.8k
Eiji Kurosaki Japan 16 993 0.8× 579 0.7× 658 0.8× 87 0.3× 190 1.1× 29 1.5k
J.C. Fruchart France 21 741 0.6× 934 1.1× 1.4k 1.7× 41 0.2× 316 1.8× 60 2.6k

Countries citing papers authored by Kiichiro Ueta

Since Specialization
Citations

This map shows the geographic impact of Kiichiro Ueta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiichiro Ueta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiichiro Ueta more than expected).

Fields of papers citing papers by Kiichiro Ueta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiichiro Ueta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiichiro Ueta. The network helps show where Kiichiro Ueta may publish in the future.

Co-authorship network of co-authors of Kiichiro Ueta

This figure shows the co-authorship network connecting the top 25 collaborators of Kiichiro Ueta. A scholar is included among the top collaborators of Kiichiro Ueta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiichiro Ueta. Kiichiro Ueta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ishii, Manabu, et al.. (2022). Characteristics of Japanese patients with non-dialysis-dependent chronic kidney disease initiating treatment for anemia: a retrospective real-world database study. Current Medical Research and Opinion. 38(12). 2175–2182. 3 indexed citations
4.
Kuriyama, Chiaki, Keiko Nakayama, Yasuaki Matsushita, et al.. (2016). Changes in glucose-induced plasma active glucagon-like peptide-1 levels by co-administration of sodium–glucose cotransporter inhibitors with dipeptidyl peptidase-4 inhibitors in rodents. Journal of Pharmacological Sciences. 132(4). 255–261. 6 indexed citations
5.
Kuriyama, Chiaki, Kiichiro Ueta, & Kenji Arakawa. (2015). Pharmacological and clinical profile of a novel SGLT2 inhibitor canagliflozin hydrate (CANAGLU<sup>®</sup>). Folia Pharmacologica Japonica. 146(6). 332–341. 4 indexed citations
6.
Nakayama, Keiko, Chiaki Kuriyama, Yasuaki Matsushita, et al.. (2015). Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents. Journal of Pharmacology and Experimental Therapeutics. 354(3). 279–289. 54 indexed citations
7.
Watanabe, Yoshinori, Keiko Nakayama, Yasushi Horai, et al.. (2015). Beneficial Effects of Canagliflozin in Combination with Pioglitazone on Insulin Sensitivity in Rodent Models of Obese Type 2 Diabetes. PLoS ONE. 10(1). e0116851–e0116851. 36 indexed citations
8.
Ueta, Kiichiro, et al.. (2013). Involvement of heparan sulfate in the renoprotective effects of imidapril, an angiotensin-converting enzyme inhibitor, in diabetic db/db mice. Journal of Receptors and Signal Transduction. 34(1). 21–25. 4 indexed citations
9.
Koga, Yuichi, Shigeki Sakamaki, Mitsuya Hongu, et al.. (2013). C-Glucosides with heteroaryl thiophene as novel sodium-dependent glucose cotransporter 2 inhibitors. Bioorganic & Medicinal Chemistry. 21(17). 5561–5572. 26 indexed citations
10.
Liang, Yin, Kenji Arakawa, Kiichiro Ueta, et al.. (2012). Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models. PLoS ONE. 7(2). e30555–e30555. 200 indexed citations
11.
Castelhano, Arlindo L., Hanqing Dong, Matthew C. T. Fyfe, et al.. (2005). Glucokinase-activating ureas. Bioorganic & Medicinal Chemistry Letters. 15(5). 1501–1504. 35 indexed citations
12.
Ueta, Kiichiro, Tomomi Ishihara, Yukio Matsumoto, et al.. (2005). Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats. Life Sciences. 76(23). 2655–2668. 72 indexed citations
13.
Adachi, Tetsuya, Koichiro Yasuda, Yoshimasa Okamoto, et al.. (2000). T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats. Metabolism. 49(8). 990–995. 76 indexed citations
14.
Oku, Akira, Kiichiro Ueta, Masao Nawano, et al.. (2000). Antidiabetic effect of T-1095, an inhibitor of Na+-glucose cotransporter, in neonatally streptozotocin-treated rats. European Journal of Pharmacology. 391(1-2). 183–192. 49 indexed citations
15.
Oku, Akira, Kiichiro Ueta, Kenji Arakawa, et al.. (2000). Antihyperglycemic Effect of T-1095 via Inhibition of Renal Na+-Glucose Cotransporters in Streptozotocin-Induced Diabetic Rats.. Biological and Pharmaceutical Bulletin. 23(12). 1434–1437. 23 indexed citations
16.
Oku, Akira, Kiichiro Ueta, Kenji Arakawa, et al.. (2000). Correction of Hyperglycemia and Insulin Sensitivity by T-1095, an Inhibitor of Renal Na+-Glucose Cotransporters, in Streptozotocin-Induced Diabetic Rats. The Japanese Journal of Pharmacology. 84(3). 351–354. 22 indexed citations
17.
Ueta, Kiichiro, et al.. (2000). Amiloride‐sensitive pressure‐induced myogenic contraction in rat cerebral artery. Fundamental and Clinical Pharmacology. 14(4). 369–377. 16 indexed citations
18.
Nawano, Masao, Kiichiro Ueta, Akira Oku, et al.. (1999). Hyperglycemia Impairs the Insulin Signaling Step between PI 3-Kinase and Akt/PKB Activations in ZDF Rat Liver. Biochemical and Biophysical Research Communications. 266(1). 252–256. 34 indexed citations
19.
Tsujihara, Kenji, Mitsuya Hongu, Kunio SAITO, et al.. (1999). Na+-Glucose Cotransporter (SGLT) Inhibitors as Antidiabetic Agents. 4. Synthesis and Pharmacological Properties of 4‘-Dehydroxyphlorizin Derivatives Substituted on the B Ring. Journal of Medicinal Chemistry. 42(26). 5311–5324. 98 indexed citations
20.
Nakayama, Koichi, et al.. (1997). Stretch‐induced contraction of rabbit isolated pulmonary artery and the involvement of endothelium‐derived thromboxane A2. British Journal of Pharmacology. 122(2). 199–208. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terrance D. Barrett Breakdown of academic impact, for papers by Uday Saxena Breakdown of academic impact, for papers by Shlomo Keidar Breakdown of academic impact, for papers by Amit Joharapurkar Breakdown of academic impact, for papers by Mark C. Kowala Breakdown of academic impact, for papers by J L Witztum Breakdown of academic impact, for papers by Gert M. Kostner Breakdown of academic impact, for papers by Timothy J. Furlong Breakdown of academic impact, for papers by Eiji Kurosaki Breakdown of academic impact, for papers by J.C. Fruchart
Rankless by CCL
2026